期刊文献+

烟碱型乙酰胆碱受体在帕金森病认知功能障碍中的作用 被引量:4

The function of nicotinic acetylcholine receptors in Parkinson's disease with cognitive disorder
下载PDF
导出
摘要 帕金森病(Parkinson’s Disease,PD)是继阿尔兹海默病(Alzheimer,AD)之后的第二大中枢神经系统退行性疾病,涉及运动及非运动症状。运动症状主要表现为缓慢进展的静止性震颤、运动迟缓、肌强直及姿势步态异常:非运动症状包括认知功能障碍、精神病样症状、自主功能障碍、嗅觉丧失、睡眠障碍等。认知功能障碍是PD最常见的非运动症状,在疾病早期,主要是注意力、执行功能、工作记忆、视空间功能受损;在疾病进展期,PD最终会发展成帕金森病痴呆(Parkinson’s diseasedementia,PDD),国外报道其发生率最高,达80%。
出处 《中国临床医学影像杂志》 CAS 2014年第12期887-889,共3页 Journal of China Clinic Medical Imaging
基金 国家自然科学基金(81000623) 辽宁省科学技术计划项目(2013225049)
  • 相关文献

参考文献25

  • 1Baba T, Kikuchi A, Hirayama K, et al. Sever olfactory dysfunc- tion is a prodromal symptom of dementia associated with Parkin- son's disease: a 3 year longitudinal study[J]. Brain, 2012, 135(1): 161-169.
  • 2Weintraub D, Comella CL, Horn S. Parkinson's disease-Part 3: Neuropsychiatric symptoms [J]. Am J Manag Care, 2008, 14(2 Suppl): S59-69.
  • 3Lewis SJG, Slabosz A, Robbins TW, et al. Dopaminergic basis for deficits in working memory but not attentional set-shifting in Parkinson's disease[J]. Neuropsychologia, 2005, 43(6): 823-832.
  • 4Hirano S, Shinotoh H, Eidelberg D. Functional brain imaging of cognitive dysfunction in Parkinson's disease [J]. J Neurol Neuro- surg Psychiatry, 2012, 83(10): 963-969.
  • 5Barrett AM, Crucian GP, Schwartz R, et al. Seeing trees but notthe forest: limited perception of large configurations in PD[J]. Neurology, 2001, 56(6): 724-729.
  • 6Meireles J, Massano J. Cognitive impairment and dementia in Parkinson's disease: clinical features, diagnosis, and management [J]. Front Neural, 2012, 3: 88.
  • 7Goldman JG, Litvan I. Mild cognitive impairment in Parkinson's disease[J]. Minerva Med, 2011, 102(6): 441-459.
  • 8Wang Q, Zhang Z, Li L, et al. Assessment of cognitive impair- ment in patients with Parkinson's disease: prevalence and risk factors[J]. Clin Interv Aging, 2014, 9: 275-281.
  • 9Bohnen NI, Kaufer DI, Ivanco I.S, et al. Cortical cholinergic function is more severely affected in parkinsonian dementia than in Alzheimer disease: an in vivo positron emission tomographic study[J]. Arch Neurol, 2003, 60(12): 1745-1748.
  • 10Bohnen NI, Koeppe RA, Minoshima S, et al. Cerebral glucose metabolic features of Parkinson disease and incident dementia: longitudinal study[J]. J Nucl Med, 2011, 52(6): 848-855.

二级参考文献18

  • 1DANI JA. Overview of Nicotinic Receptors and Their Roles in the Central Nervous System [J]. Biol Psychiatry, 2001, 49 : 166-174.
  • 2SIHVER W, LANGSTROM B, NORDBERG A. Ligands for in Vivo Imaging of Nicotinic Receptor Subtypes in Alzheimer Brain [J]. Acta Neurol Scand, 2000, 176 (Suppl):27-33.
  • 3PATERSON D, NORDBERG A. Nicotinic Acetylcholine Receptor and Imaging [J]. Prog Neurobiol, 2000, 61:75-111.
  • 4VALETTE H, BOTTLAENDER M, DOLLE F, et al. An Attempt to Visualize Brain Nicotinic Receptors With ^11C-ABT-418 and N-^11 C-methyl Cytisine[J]. Nucl Med Commun, 1997, 18:164-168.
  • 5ROGER G, LAGNEL B, ROUDEN J. Synthesis of a 2-pyridiny1-^18 F-labeled Fluoro Derivative of (-)-cytisine as a Candidate Radioligand for Brain Nicotinic α4β2 Receptor Imaging With PET[J]. Bioorg Med Chem, 2003,11:5 333-5 343.
  • 6HOLLADAY MW, DART MJ, LYNCH JK. Neuronal Nicotinic Acetylcholine Receptors as Targets for Drug Discovery[J]. J Med Chem, 1997, 40 (26):4 169-4 194.
  • 7BOTTLAENDER M, VALETTE H, ROUMENOV D, et al. Biodistribution and Radiation Dosimetry of ^18F-fluoro-A-85380 in Healthy Volunteers [J]. J Nucl Med, 2003, 44 (4):596-601.
  • 8DOLLE F, VALETTE H, BOTTLAENDER M, et al. Synthesis of 2-[^18F] Fluoro-3-[2(S)- azetidinylmethoxy] Pyridine, a Highly Potent Radioligand for in Vivo Imaging Central Nicotinic Acetylcholine Receptors [J]. J Labeled Compd Radiopharm, 1998, 41:451-463.
  • 9DOLLE F, DOLCI L, VALETTE H, et al. Synthesis and Nicotinic Acetylcholine Receptor in Vivo Binding Properties of 2-Fluoro-3-[2(S)-azetidinylmethoxy] pyridine: a New Positron Emission Tomography Ligand for Nicotinic Receptors[J]. J Med Chem, 1999, 42:2 251-2 259.
  • 10MITKOVSKI S, VILLEMAGNE VL, NOVAKOVIC KE, et al. Simplified Quantification of Nicotinic Receptors With 2[^18F] F-A-85380 PET[J]. Nucl Med Biol, 2005, 32(6):585-591.

共引文献6

同被引文献32

引证文献4

二级引证文献7

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部